glp 1 compounding update 🚨 FDA — April 1, 2026 (GLP-1 Just Changed), Most pharmacies haven’t realized what the latest FDA clarification actually means., On April 1, 2026, the U.S. Food and Drug Compound versions of GLP-1 drugs

No particles

GLP-1 medications are a hot topic across the health industry as the health benefits are on the rise

Glucose Control is the specifically studied formula for post-meal glucose support in adults with type 2 diabetes

Noom charges $279/month for compounded semaglutide injections ($852.27 every 12 weeks with tax), but the first month is discounted at $129

Essential Baseline Assessment Depending on the treatment indication and medical history, a baseline assessment may include: Hemoglobin A1C Glucose Test Comprehensive Metabolic Panel Lipid Panel Complete Blood Count when clinically appropriate Kidney Profile or urine albumin-to-creatinine testing for relevant diabetes or kidney risk Early Follow-Up Follow-up may be considered after treatment initiation, dose escalation, or a clinically meaningful change in symptoms

A clear reading of FDA guidance says that a prescriber can authorize a custom formulation of semaglutide or tirzepatide, says Scott Brunner, the CEO of the Alliance for Pharmacy Compounding